Market Cap (In INR)
225.28 Billion
Revenue (In INR)
10.16 Billion
Net Income (In INR)
3.08 Billion
Avg. Volume
8180.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1277.75-2658.0
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- INE338H01029
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Ankur Vaid
- Employee Count
- -
- Website
- https://www.concordbiotech.com
- Ipo Date
- 2023-08-18
- Details
- Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. It provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. The company also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment; mupirocin, mupirocin calcium, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, and micafungin sodium for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.
More Stocks
-
RAMCOSYSRamco Systems Limited
RAMCOSYS
-
CRISILCRISIL Limited
CRISIL
-
SUPERHOUSESuperhouse Limited
SUPERHOUSE
-
MPFRYMapfre, S.A.
MPFRY
-
SGHIF
-
PDRDFPernod Ricard SA
PDRDF
-
5195
-
RGRNFRegis Resources Limited
RGRNF